Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.


Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 21 5 2019
pubmed: 21 5 2019
medline: 24 12 2019
Statut: ppublish

Résumé

During the 2008-2012 pertussis epidemic in Australia, pertactin (Prn)-negative Bordetella pertussis emerged. We analyzed 78 isolates from the 2013-2017 epidemic and documented continued expansion of Prn-negative ptxP3 B. pertussis strains. We also detected a filamentous hemagglutinin-negative and Prn-negative B. pertussis isolate.

Identifiants

pubmed: 31107218
doi: 10.3201/eid2506.180240
pmc: PMC6537726
doi:

Substances chimiques

Adhesins, Bacterial 0
Bacterial Outer Membrane Proteins 0
Pertussis Vaccine 0
Virulence Factors, Bordetella 0
filamentous hemagglutinin adhesin, Bordetella pertussis 0
pertactin 63GD90PP8X

Types de publication

Historical Article Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1196-1199

Références

FEMS Immunol Med Microbiol. 1996 Feb;13(2):169-78
pubmed: 8731026
mBio. 2014 Apr 22;5(2):e01074
pubmed: 24757216
J Infect Dis. 2012 Apr 15;205(8):1220-4
pubmed: 22416243
Emerg Infect Dis. 2017 Apr;23(4):699-701
pubmed: 28322702
J Proteomics. 2017 Mar 31;158:43-51
pubmed: 28242451
J Infect. 2016 Apr;72(4):468-77
pubmed: 26826518
PLoS One. 2012;7(2):e31985
pubmed: 22348138
PLoS One. 2012;7(10):e46688
pubmed: 23056405
Mol Biol Evol. 2011 Jan;28(1):707-15
pubmed: 20833694
Clin Vaccine Immunol. 2014 Feb;21(2):119-25
pubmed: 24256623
J Bacteriol. 2017 Mar 28;199(8):
pubmed: 28167525
Genome Announc. 2017 Sep 14;5(37):
pubmed: 28912323
Emerg Infect Dis. 2014 Apr;20(4):626-33
pubmed: 24655754

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH